NDC 61958-3401 – Yeztugo

Lenacapavir Sodium 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC61958-3401

Product details

Brand name
Yeztugo
Generic name
Lenacapavir Sodium
Labeler
Gilead Sciences, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA220020
Marketed since
June 18, 2025
Listing expires
December 31, 2027
Pharmacologic class
Human Immunodeficiency Virus 1 Capsid Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Yeztugo →

Package NDC codes (1)

Package NDCDescriptionSince
61958-3401-14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3401-1)Jun 18, 2025

Other Yeztugo products